Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus. - Wikidata - awgldk - TriplyDB

Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus.

Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus.

http://www.wikidata.org/entity/Q36376850

about

Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin Human autoimmune sera as molecular probes for the identification of an autoantigen kinase signaling pathway Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies Carbamylation-dependent activation of T cells: a novel mechanism in the pathogenesis of autoimmune arthritis Death, autoantigen modifications, and tolerance.The 72-kDa component of signal recognition particle is cleaved during apoptosis Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemia.Rapid lupus autoantigen relocalization and reactive oxygen species accumulation following ultraviolet irradiation of human keratinocytes.Protein arrays for studying blood cells and their secreted products.Comparative quantitative mass spectrometry analysis of MHC class II-associated peptides reveals a role of GILT in formation of self-peptide repertoire Immunogenicity of autoantigens.Proteolytic cleavage of the catalytic subunit of DNA-dependent protein kinase during poliovirus infection.NETs: the missing link between cell death and systemic autoimmune diseases?Photosensitivity in lupus erythematosus.Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis.Proteomics technologies for the study of autoimmune disease.The U1-snRNP complex: structural properties relating to autoimmune pathogenesis in rheumatic diseases.Triggers for anti-chromatin autoantibody production in SLE.Analysis of in vivo role of alpha-fodrin autoantigen in primary Sjogren's syndrome Role of α-synuclein in inducing innate and adaptive immunity in Parkinson disease.Soluble CD95 concentrations are increased in patients with severe systemic lupus erythematosus, but not in their first degree relatives.Differential effect of IL10 and TNF{alpha} genotypes on determining susceptibility to discoid and systemic lupus erythematosus.Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement Altered autoantigen structure in Sjögren's syndrome: implications for the pathogenesis of autoimmune tissue damage.Manipulation of the glycan-specific natural antibody repertoire for immunotherapy Anti-phospholipid antibodies (aPL) and apoptosis: prothrombin-dependent aPL as a paradigm for phospholipid-dependent interactions with apoptotic cells.Association of phosphorylated serine/arginine (SR) splicing factors with the U1-small ribonucleoprotein (snRNP) autoantigen complex accompanies apoptotic cell death.Autoimmunity to isomerized histone H2B in systemic lupus erythematosus.The role of tumor necrosis factor-alpha in systemic lupus erythematosus Inflammatory clearance of apoptotic cells after UVB challenge.IL-10 and TNFalpha genotypes in SLE.Autoantigenesis: the evolution of protein modifications in autoimmune disease.The applied basic research of systemic lupus erythematosus based on the biological omics.Autoantigens: novel forms and presentation to the immune system.An anti-DNA antibody prefers damaged dsDNA over native.Exposure of HEp-2 cells to stress conditions influences antinuclear antibody reactivity.Isoaspartyl post-translational modification triggers anti-tumor T and B lymphocyte immunity.Aberrant HS1 molecule in a patient with systemic lupus erythematosus.Dendritic cell presentation of antigens from apoptotic cells in a proinflammatory context: role of opsonizing anti-beta2-glycoprotein I antibodies.

P2860

Q21195679-48AE24B1-904C-46DA-96D0-652CB3355737 Q24316154-3854F8A4-117C-4307-B11A-6CBAD8434B07 Q24564876-555B26F6-F2A6-443A-B0A5-BDAD47D0B2F3 Q24629328-3CA1A03D-9D9D-4441-9DC3-ADB41C2EA38F Q24806787-EF2CA6F7-6BC2-4D93-B672-2CE8CEC31F60 Q28291832-EC71F335-F766-4C5F-B22A-263DB49657C1 Q28344126-F207372B-5A57-4332-A997-134C7507AC3B Q30412320-8E684D96-D4D7-456F-8556-E6591C225C19 Q33180258-80A8312B-6BF2-499E-8375-23DBC520604D Q33213208-D31190E0-30D5-4F8E-95B5-39D925289AA2 Q33582318-DF5C050A-E4E3-40F3-9F30-3B824E9EEC30 Q33949907-2D6C76E1-E25E-4CFC-80E3-B550DAB3FE40 Q34186037-3111EE6A-FC8F-4CCA-9A00-1C1B41A47BC8 Q34323566-3FAFA892-CE56-4F00-AA03-3918B611EB97 Q34349866-D484042F-6952-48F8-A394-6B6492E9AE4C Q34498921-75AF66CB-D197-4408-B65C-449042D9F908 Q34601748-EFA351B0-8B96-4C96-8DBC-2A479E1B700B Q34779998-E666397E-6426-4ACE-AA2F-7DA414A82F4A Q35045914-8DAE8494-45A2-4EE4-8A9E-1AEB98B6A1BB Q35085204-C4C56C73-CBBA-4D64-A42B-A452D6E08196 Q35510197-27951155-E356-404A-BAF1-A1C76BBFBC7F Q35550238-403AFB1B-733A-4F4F-92F0-930FC7949F4E Q35554902-50E4A17E-09BB-49BC-85A5-693DABE95B64 Q35636552-7E0D3FAF-B595-417E-9AE9-155D92C414CA Q35798719-C0864EDF-E919-42F6-880D-F3BECCCE9EF3 Q35920081-00976BED-BCFC-4DF6-BA0C-0E03160BA663 Q35928668-470A8A5E-C7CD-4EEB-9312-8AF7C0EA62A8 Q36400294-77C56894-9311-442E-9CE4-7BD78622B247 Q36527598-2459F89A-BD7A-43BD-8762-2720711F6290 Q36641608-CBBE9581-DDDD-4427-BA89-7E475706B44C Q36827912-B8BEA8C8-0386-40A0-975B-2889CE269695 Q37772082-27B93DA5-76A9-45AE-AFEF-BAF6A7584CFB Q37972473-A4954B0D-86F4-4E09-B48E-B4A917DE7FB8 Q38085206-862FF4C0-97E2-4D86-90E1-3DD73983D67D Q38160040-95F69C1E-AB0C-4952-8C11-DFAC5583E054 Q38294894-B99ED0EA-2F0F-43E2-9A7D-8EDC223732CD Q39625508-339FF5F2-D85D-4E20-93CD-A8909883CECB Q40236620-972A0164-5064-4BBC-A015-36A2A0973D02 Q40666395-2F11A1D8-500D-4EAE-8C93-509C97CA2853 Q40942556-7B6BD8AE-E39D-4E73-A9BA-FE067F4CF4A5

P2860

Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus.

http://www.wikidata.org/entity/Q36376850

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年学术文章

@wuu

1997年学术文章

@zh-cn

1997年学术文章

@zh-hans

1997年学术文章

@zh-my

1997年学术文章

@zh-sg

1997年學術文章

@yue

1997年學術文章

@zh

1997年學術文章

@zh-hant

name

Proteins phosphorylated during ...... systemic lupus erythematosus.

@ast

Proteins phosphorylated during ...... systemic lupus erythematosus.

@en

type

label

Proteins phosphorylated during ...... systemic lupus erythematosus.

@ast

Proteins phosphorylated during ...... systemic lupus erythematosus.

@en

prefLabel

Proteins phosphorylated during ...... systemic lupus erythematosus.

@ast

Proteins phosphorylated during ...... systemic lupus erythematosus.

@en

P1433

Q36376850-EE0A7AF6-CCE0-4956-A6EB-7B9C9200DBF1

P1476

Q36376850-FBA79838-8074-42D0-9FE9-334C7567693F

P2093

Q36376850-8CF96E9C-2F47-4A30-A8B6-C8212193A444

Q36376850-AF3DDC8F-2F37-456C-9EC0-29257F2F5C42

Q36376850-B697BCDE-AACE-41DC-9CB1-40E1FDDFDD6C

Q36376850-E4E735B4-C035-4997-8E01-899CC1AAA92A

P2860

Q36376850-042F707F-02DA-4E8C-A6DA-D0D0E0CEE9FC

Q36376850-0FC3DDD4-E00C-4098-9C62-F84B96D5B1B5

Q36376850-1482296C-0D22-46CF-90F4-CA5384545A32

Q36376850-1679140C-1B60-4C2F-A2DF-A167F5CDCABE

Q36376850-191DE1D3-C9B7-4882-BE95-8E065AAB355F

Q36376850-1E42870D-D4D0-43FD-AD8A-BE3DD3732F47

Q36376850-2A228A71-7CEE-4EF0-92FA-A6F774DBE466

Q36376850-2D7DCBC1-5305-4DA6-A615-CA3067070B07

Q36376850-327D4CFD-EF1D-4F82-93ED-18D189F98ADA

Q36376850-3365989D-F9FD-414E-8AD5-53B52181C4C5

P304

Q36376850-A9E9CAC4-69E0-4CD7-AE17-5D03D8150EB3

P31

Q36376850-925B5674-0A48-4BD7-8B00-6AFA7782241A

P356

Q36376850-5260AB28-3F4A-4715-A7B6-30FE4867E206

P407

Q36376850-0728228F-99D5-4628-ABBB-EC37320F4308

P433

Q36376850-1C27BD7E-90C9-4A1B-A51E-034C3B8C6CC0

P478

Q36376850-9274EAC5-DC4C-4E4B-ACEB-D5C650860AA0

P577

Q36376850-88993763-5A11-4C1C-9F48-D24CF31F3D6B

P5875

Q36376850-CF333B33-F20B-4F92-B0B0-BD60D258DD0C

P698

Q36376850-F1693041-C9C4-4054-94E4-A66165C6174E

P921

Q36376850-06DF9881-44F4-407C-A84F-E9A3D3E344D8

Q36376850-15A791AC-6973-4E07-BE1D-3CD9A18CB1E4

Q36376850-9C5BE72D-96B6-4050-8F7A-064DEAC53CBE

P932

Q36376850-CB97C1C5-1297-46A2-A853-ED9F302BDE16

P356

P1433

Journal of Experimental Medicine

P1476

Proteins phosphorylated during ...... systemic lupus erythematosus.

@en

P2093

M Hottelet

http://www.w3.org/2001/XMLSchema#string

P Anderson

http://www.w3.org/2001/XMLSchema#string

P H Schur

http://www.w3.org/2001/XMLSchema#string

P J Utz

http://www.w3.org/2001/XMLSchema#string

P2860

Fas-activated serine/threonine kinase (FAST) phosphorylates TIA-1 during Fas-mediated apoptosis

JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain

A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells

The RNA-binding protein TIAR is translocated from the nucleus to the cytoplasm during Fas-mediated apoptotic cell death

Bcl-2 interacting protein, BAG-1, binds to and activates the kinase Raf-1

Cleavage of structural proteins during the assembly of the head of bacteriophage T4

Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis

Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase

The 1982 revised criteria for the classification of systemic lupus erythematosus

Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis

P304

843-854

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.185.5.843

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

185

http://www.w3.org/2001/XMLSchema#string

P577

1997-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273559183

http://www.w3.org/2001/XMLSchema#string

P698

9120390

http://www.w3.org/2001/XMLSchema#string

P921

apoptotic process

phosphorylation

P932

2196161

http://www.w3.org/2001/XMLSchema#string